A thorough chemical description of abacavir sulfate, identified by the CAS number 188062-50-2, demonstrates it is a synthetic guanine analog used as an anti-HIV agent. Chemically, it exists as a sulfate form, contributing to enhanced dissolvability compared to the free compound. Its chemical formula is C14H15N6O4S and demonstrates a molecular of approximately 385.41 g/mol. Moreover, abacavir sulfate operates by inhibiting retroviral reverse transcriptase, a essential enzyme for retroviral replication.
```text
Abarelix (183552-38-7): Attributes, Applications , and Harmlessness
Abarelix, identified by the CAS number 183552-38-7 , is a laboratory-created protein designed primarily for the treatment of glandular enlargement (BPH). Its principal characteristics include being a highly specific stimulator of GnRH receptors. Clinically , it’s employed to diminish male hormone amounts and as a result alleviate the aden and its associated symptoms . Concerning safety , while generally perceived, abarelix can trigger adverse effects , including administration site inflammation, flushing , and conceivably serious cardiovascular events . Therefore, precise individual monitoring and suitable dosing are vital. Additional research continues to explore its full therapeutic potential and refine its harmlessness profile .
```
Abiraterone Acetate (154229-18-2): Synthesis and Pharmaceutical Relevance
Abiraterone ANISODINE HYDROBROMIDE 76822-34-9 salt compound , a potent inhibitor of androgen biosynthesis , has emerged as a significant pharmaceutical medication in the therapy of metastatic prostate malignancy . Distinct synthetic routes have been described for its manufacture , often involving complex biomolecular reactions . Key strategies include pyridinyl ring building and following copyright framework alteration . The obtained abiraterone salt is then transformed to a medically acceptable form. The therapeutic significance stems from its ability to lower testosterone levels, thereby restricting cancer tissue proliferation and boosting patient outcomes . Further study continues to examine innovative synthetic methodologies and prospective applications of this crucial healing compound .
- Different synthetic routes have been established .
- Abiraterone operates as an inhibitor .
Understanding Abacavir Sulfate: CAS 188062-50-2 Explained
Abacavir or sulfate, recognized by its Chemical Abstracts Service (CAS) Registry Number 188062-50-2, is a significant antiretroviral agent employed in the management of HIV disease. The compound functions as a nucleoside reverse transcriptase inhibitor, effectively halting the infection from replicating within the body. Understanding its properties and action is essential for medical professionals and individuals receiving this prescription therapy; furthermore, genetic testing is needed prior to start of abacavir therapy to evaluate risk of a hypersensitivity response.
Understanding CAS Number Breakdown: Analyzing Abarelix (183552-38-7)
The CAS Designation 183552-38-7 refers to abarelix, a decapeptide used primarily in treating prostate malignancies . Its specific identifier allows for accurate recognition of this distinct molecule within scientific databases and studies. Abarelix functions by inhibiting gonadotropin-releasing hormone (GnRH), significantly suppressing testosterone levels . Further data regarding the compound's characteristics , safety information and medical roles can be located using this standardized registry number .
- Peptide Structure
- Therapeutic Activity
- Compliance Status
Abiraterone Acetate (154229-18-2): Chemical Data and Therapeutic Uses
Abiraterone acetate acetate (CAS Registry Number 154229-18-2) represents a engineered copyright antagonist of male hormone production. Chemically, it's defined as (3β)-alcohol-21spiro-ring-5androstane analog, and its molecular formula is C26H30O3. Its primary medical use is in the management of metastatic adenocarcinoma disease, often in combination with copyright medication. Research indicate it effectively decreases androgen concentrations in patients, leading to improved prognosis. The drug works by blocking the protein 17α-hydroxylase/C17,20-lyase, which is important for testosterone creation within the adrenal structures and gonads.